|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection显示文摘 | European Association for the Study of the Liver | 2012 | Journal of Hepatology2012，，1： | 62 |
| 2 | EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma显示文摘 | European Association for the Study of the Liver European Organisation for Research and Treatment of Cancer | 2012 | Journal of Hepatology2012，，4： | 41 |
| 3 | 1970~1992年欧洲输气管道事故显示文摘为了更有效地掌握输气管道事故发生的频率和原因,欧洲主要的输气公司对1970~1992年的输气管道进行了调查,详细统计和分析了管道事故频率与直径、壁厚及埋深的关系。事故原因可分为以下几种:①外部影响;②施工缺陷和材料失效;③腐蚀;④地面运动;⑤现场开口、接管的失误(计划外开口)等等。外部影响是输气管道泄漏事故的主要原因之一,较小管道的事故频率一直高于较大管道,管子埋得越深,外部影响越小。针对各类管道事故,通过采用较好的覆盖层和有效的监控及维修,提高管道制造和施工标准,各种类型的管道事故都有所下降。 | 姜俊荣 丁建林 European Gas Pipeline Incident Data Group | 1997 | 油气储运1997，16，5： | 13 |
| 4 | EASL Clinical Practice Guidelines: Management of cholestatic liver diseases显示文摘 | European Association for the Study of the Liver | 2009 | Journal of Hepatology2009，，2： | 10 |
| 5 | 西欧4国高速铁路系统考察报告显示文摘较全面地介绍了欧洲以及德国、法国、西班牙、意大利高速铁路发展情况及特点,也涉及到摆式列车和磁浮铁路,归纳了考察的收获与体会。 | Investigation Group of High-speed Railways in Four West European Countries | 1998 | 中国铁路1998，，6： | 8 |
| 6 | EASL Clinical Practice Guidelines: Management of chronic hepatitis B显示文摘 | European Association for the Study of the Liver | 2009 | Journal of Hepatology2009，，2： | 7 |
| 7 | EASL Clinical Practice Guidelines: Management of chronic hepatitis B显示文摘 | European Association for the Study of the Liver | 2009 | Journal of Hepatology2009，，2： | 6 |
| 8 | EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection显示文摘 | European Association for the Study of the Liver | 2012 | Journal of Hepatology2012，，1： | 6 |
| 9 | EASL Clinical Practice Guidelines:management of cholestatic liver diseases显示文摘 | European Association for the Study of the Liver | | Journal of Hepatology0，，： | 4 |
| 10 | Microbiome in the setting of burn patients:implications for infections and clinical outcomes显示文摘Burn damage can lead to a state of immune dysregulation that facilitates the development of infections in patients.The most deleterious impact of this dysfunction is the loss of the skin’s natural protective barrier.Furthermore,the risk of infection is exacerbated by protracted hospitalization,urinary catheters,endotracheal intubation,inhalation injury,arterial lines and central venous access,among other mainstays of burn care.Currently,infections comprise the leading cause of mortality after major burn injuries,which highlights the improvements observed over the last 50 years in the care provided to burn victims.The need to implement the empirical selection of antibiotic therapy to treat multidrug-resistant bacteria may concomitantly lead to an overall pervasiveness of difficult-to-treat pathogens in burn centres,as well as the propagation of antimicrobial resistance and the ultimate dysregulation of a healthy microbiome.While preliminary studies are examining the variability and evolution of human and mice microbiota,both during the early and late phase burn injury,one must consider that abnormal microbiome conditions could influence the systemic inflammatory response.A better understanding of the changes in the postburn microbiome might be useful to interpret the provenance and subsequent development of infections,as well as to come up with inferences on the prognosis of burn patients.This review aims to summarise the current findings describing the microbiological changes in different organs and systems of burn patients and how these alterations affect the risks of infections,complications,and,ultimately,healing. | Silvia Corcione Tommaso Lupia Francesco G.De Rosa on behalf of Host and Microbiota Interaction Study Group(ESGHAMI)of the European Society of Clinical Microbiology and Infectious Diseases(ESCMID) | 2020 | Burns & Trauma2020，8，1： | 3 |
| 11 | EASL clinical practice guidelines on the management of ascites,spontaneous bacterial peritonitis,and hepatorenal syndrome in cirrhosis显示文摘 | European Association for the Study of the Liver Gines P Angeli P | | Journal of Hepatology0，，： | 2 |
| 12 | EASL Clinical Practice Guidelines:Management of chronic hepatitis B显示文摘 | European Association For The Study Of The Liver | | Journal of Hepatology0，，： | 2 |
| 13 | EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma显示文摘 | European Association for the Study of the Liver European Organisation for Research and Treatment of Cancer | 2012 | Journal of Hepatology2012，，4： | 2 |
| 14 | 临床实践要点——欧洲骨结合协会2018会议共识显示文摘欧洲骨结合协会(European Association of Osseointegration,EAO)是一个成立于1991年旨在为全球骨整合及口腔种植领域专家提供国际化、跨学科学术交流平台的非营利性组织。自2006年以来,EAO每3年举办1次共识会议(consensus conference),邀请各领域的专家讨论与口腔种植学相关的热点话题。2018年2月,来自世界各地的60名科学家参加了在瑞士举行的共识会议。针对药物使用和疾病、生物因素、修复重建、生物机械等四大主题展开循证讨论并形成会议共识。该会议共识之'临床实践要点'将共识会议讨论中涉及的大量临床研究和综述性汇报的结果进行精炼和总结,以问答形式回答临床工作中遇到的问题,具有较强的临床指导性。需要指出的是,基于现有研究总结出的共识要点既体现了一定的先进性,同时也不可避免地具有一些局限性。在某些领域因证据不足尚无法获得确切的结论和指导意见。现将这些有争议性的话题和观点呈现于此,供大家分析讨论,同时也希冀广大口腔医师能正视口腔种植学的发展现状,努力将研究结果与临床实践相结合,更好地服务于临床。 | European Association for Osseointegration 杨静文 张海东 | 2019 | 中华口腔医学杂志2019，54，5： | 2 |
| 15 | Late lessons from early warnings the precautionary principle 1896-2000显示文摘 | European Environment Agency | 2001 | Environ Issue Report2001，22，： | 2 |
| 16 | Guidelines for management of ischaemic stroke and transient ischaemic attack 2008显示文摘 | European Stroke Organisarion (ESO) Executive Committee ESO Writing Committee | | Cerebrovascular Diseases0，，： | 2 |
| 17 | Directive on the approximation of the laws, regulations and administrative provisions of the Member States concerning liability for defective products显示文摘 | European Union Directive 85/374/EEC | 1985 | Official Journal1985，，210： | 1 |
| 18 | Commission regulation (EC) No 2073/2005 of 15 November 2005 on microbiological criteria for foodstuffs 显示文摘 | The commission of the european communities | 2005 | Official Journal of the European Union2005，338，： | 1 |
| 19 | Guidelines on diagnosis and managemerit of acute pnlmonary embolism显示文摘 | | 2000 | Eur Heart J2000，21，16： | 1 |
| 20 | MRC European Carotid Surgery Trial:interim results for symptomatic patients with severe (70%-99%) or with mild (0-29%)carotid stenosis显示文摘 | | 1991 | Lancet1991，337，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员